Exosens, a high-tech company specializing in mission- and performance-critical amplification, detection, and imaging technologies, has secured a €140 million financing facility with the European Investment Bank (“EIB”). The facility will support the Group’s research, development, and innovation activities, as well as selected industrial investments serving European defense, surveillance, and industrial end markets, which benefit from strong structural growth drivers.
ING und die Europäische Investitionsbank (EIB) mobilisieren gemeinsam 800 Millionen Euro für Investitionen, die kleine und mittlere Unternehmen (KMU) sowie Midcap‑Unternehmen in den Niederlanden und Belgien langfristig zukunftsfähiger und nachhaltiger machen. Zu diesem Zweck vergibt die EIB einen Kredit über 400 Millionen Euro an die ING, die selbst ebenfalls 400 Millionen Euro für diese Finanzierungen zur Verfügung stellt.
The European Investment Bank Group, consisting of the European Investment Bank (EIB) and its subsidiary, the European Investment Fund (EIF), again recorded a high level of activity in Belgium in 2025. The EIB Group put its financial power behind key issues, such as social and affordable housing, energy efficiency, and energy and water infrastructure in the framework of the green transition. At the same time, the EIF supported entrepreneurship and access to finance by supporting local intermediaries and investment funds that support innovative Belgian businesses.
